1431872-99-9 Usage
Description
6-chloro-3-(1-methyl-1H-pyrazol-4-yl)pyrido[2,3-b]pyrazine is a heterocyclic chemical compound with the molecular formula C14H10ClN5. It features a chloro-substituted pyrido[2,3-b]pyrazine ring fused with a pyrazolyl group at the 3-position, making it a pyrazine derivative. 6-chloro-3-(1-methyl-1H-pyrazol-4-yl)pyrido[2,3-b]pyrazine may have potential applications in various fields such as pharmaceuticals, agrochemicals, or materials science, but further research and testing are required to determine its specific properties and uses.
Uses
Used in Pharmaceutical Industry:
6-chloro-3-(1-methyl-1H-pyrazol-4-yl)pyrido[2,3-b]pyrazine is used as a potential pharmaceutical compound for its possible biological activities and therapeutic effects. Its unique structure may contribute to the development of new drugs targeting specific diseases or conditions.
Used in Agrochemical Industry:
In the agrochemical field, 6-chloro-3-(1-methyl-1H-pyrazol-4-yl)pyrido[2,3-b]pyrazine may be utilized as a potential active ingredient in pesticides or herbicides. Its chemical properties could offer new ways to control pests or weeds in agriculture.
Used in Materials Science:
6-chloro-3-(1-methyl-1H-pyrazol-4-yl)pyrido[2,3-b]pyrazine may also find applications in materials science, where its heterocyclic structure could be employed to develop new materials with specific properties, such as improved conductivity, stability, or other desired characteristics.
Check Digit Verification of cas no
The CAS Registry Mumber 1431872-99-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,3,1,8,7 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1431872-99:
(9*1)+(8*4)+(7*3)+(6*1)+(5*8)+(4*7)+(3*2)+(2*9)+(1*9)=169
169 % 10 = 9
So 1431872-99-9 is a valid CAS Registry Number.
1431872-99-9Relevant articles and documents
NEW COMPOUNDS
-
, (2014/01/07)
The invention relates to new pyridopyrazine and naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
